India's pharmaceutical industry is urging its government to negotiate with Washington from a “position of power” on tariffs ...

India has emerged as an increasingly significant player in the illicit fentanyl trade, according to a new intelligence report ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

India has emerged as a growing player in the illicit fentanyl trade, a new US intelligence report says, a designation likely ...

Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could ...

Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.

Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

President Trump announced impending tariffs on the pharmaceutical industry and reiterated the imposition of 25% tariffs on ...